The Hybribio Thalassemia GenoArray Diagnostic Kit is designed for detection of α-thalassemia and β-thalassemia from each blood sample. Biotinylated primers were designed for specific amplification of α-globin gene deletion / mutation regions and β-gene deletion / mutation region respectively.
Amplified DNA amplicons are then hybridized with the immobilized specific thalassemia probes located on the HybriMem under the patented“flow-through hybridization”technique.Enzyme immunoassay method is applied for color development in order to obtain test results to differentiate the patient is whether heterozygous or homozygous thalassemia gene carrier.
Detection of alpha and beta thalassemia mutation and deletion
Compatible for use with whole blood, cord blood, dried blood spot and amniotic fluid samples and chorionic villus sample (CVS)
CE-IVD marked and CFDA registered
US patented Flow-through Hybridization Technology
High sensitivity and specificity (compared to CFDA approved kit)
Advantage
1.Rapid and accurate identification of mutations related to G6PD deficiency in one single test
2.Easy to operate with 1 hour hands-on time, result available within 3 hours
3.Simple and direct result interpretation
4.Effective and cost-efficient
5.Able to differentiate homozygous/ heterozygous carrier